Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 211

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part I, Item 8
Chunk 211
---
 $(0.13)$17.52 $7.13 $(0.08)$7.05 

The following outstanding employee stock options were not included in the computation of diluted earnings per share because their effect was anti-dilutive:Three Months Ended September 30,Nine Months Ended September 30,(In millions)2025202420252024Anti-dilutive options2.1 0.8 1.9 1.0 

The Company held approximately 137.4 million shares of common stock in treasury as of September 30, 2025, 128.7 million shares as of December 31, 2024 and 122.5 million shares as of September 30, 2024.

13

Note 7 – Debt

Short-Term and Long-Term Debt. During the nine months ended September 30, 2025, the Company redeemed at par its $700 million 5.685% senior notes that were due March 2026 and repaid $900 million 3.250% senior notes that matured in April 2025. For more information regarding our short-term and long-term debt, see Note 7 of the Company's 2024 Form 10-K.

Debt Issuance. In September 2025, we issued $4.5 billion of new senior notes, as detailed in the table below. The proceeds from this debt issuance were used to repay the $2.0 billion of loans outstanding under the Term Loan Facility as described below. We used the remaining net proceeds for general corporate purposes, including investments and repayment of indebtedness. Interest on this debt is paid semiannually.PrincipalMaturity DateInterest RateNet ProceedsRedeemable Date(1)"Make Whole" Premium (2)$1,000 millionSeptember 15, 20304.500%$994 millionAugust 15, 203015$1,250 millionSeptember 15, 20324.875%$1,245 millionJuly 15, 203215$1,500 millionJanuary 15, 20365.250%$1,490 millionOctober 15, 203515$750 millionJanuary 15, 20566.000%$736 millionJuly 15, 205520(1) Redeemable at any time prior to this date at a "make whole" premium, defined below. Redeemable at par on or after this date.(2) "Make whole" premium calculated